Information on EV3
Basic details
Name: Epidermodysplasia verruciformis, susceptibility to, 3 | Acronym: EV3
Alt. names:
Gene: CIB1 | MOI: Autosomal recessive | Mechanism of action:
No. of cases in DB: 0 | First reported in: 2018
Last updated on: 2023-02-28 16:41:18 by
Description
Among other findings, individuals have been described as being at increased risk of nonmelanoma skin cancer (as well as other skin neoplasms), and awareness have allowed increased surveillance and management. Refs. PMIDs: 28646613; 30068544
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
| SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
|---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
| Rank | Clinical term | Present | Absent | Unreported |
|---|---|---|---|---|
| 1 | Warts |
24 (99.9%) | 0 (0.0%) | 0 (0.0%) |
| 2 | Childhood onset |
16 (69.6%) | 0 (0.0%) | 7 (30.4%) |
| 3 | Squamous cell carcinoma |
14 (66.7%) | 0 (0.0%) | 7 (33.3%) |
| 4 | Juvenile onset |
6 (26.1%) | 0 (0.0%) | 17 (73.9%) |
| 5 | Basal cell carcinoma |
3 (12.5%) | 0 (0.0%) | 21 (87.5%) |
| 6 | Young adult onset |
1 (4.4%) | 0 (0.0%) | 22 (95.7%) |
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
| Treatment ⓘ | Responses & clinical indications |
|---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.